A randomized, double blind, parallel, placebo‐controlled study to investigate the efficacy of Lactobacillus paracasei N1115 in gut development of young children
Open Access
- 1 September 2021
- journal article
- research article
- Published by Wiley in Food Science & Nutrition
- Vol. 9 (11) , 6020-6030
Abstract
In this clinical trial, the safety and effectiveness of Lactobacillus paracasei N1115 (LP N1115) were investigated as a potential probiotic to enhance gut development in young children born by caesarean section. Infants and young children between the ages of 6 months and 3 years were administered with a probiotic consisting of LP N1115 strain (n = 30) or placebo supplement (n = 30) over an 8 weeks intervention. And the stool consistency, bowel habits, salivary cortisol, fecal microbiota, and short‐chain fatty acid metabolism were investigated. Efficacy data were obtained from 58 participants who completed the study. Overall, the placebo functioned similarly to LP N1115 group in relation to stool consistency, gastrointestinal symptoms, salivary cortisol, and short‐chain fatty acids. However, the scoring data relating to the 6–18 months subgroup receiving LP N1115 remained stable over 8 weeks in comparison to placebo. Analysis of the fecal microbiota using 16S rRNA amplicon sequencing revealed that the phyla Firmicutes represented 62% of the microbial relative abundance in the feces of the subjects during the intervening period. No significant changes in alpha‐ or beta‐diversity were noted between the placebo and LP N1115 groups overtime and at each time point. Differential abundance analysis indicated an increase in Lactobacillus in LP N1115 group at weeks 4 (p < .05) and 8 (p < .05) in comparison to the placebo group. These results suggest that probiotic supplementation with LP N1115 was well tolerated by the young children and subtle changes in the microbiome were noted throughout the intervention period.Keywords
This publication has 38 references indexed in Scilit:
- Establishment of the intestinal microbiota and its role for atopic dermatitis in early childhoodJournal of Allergy and Clinical Immunology, 2013
- Cesarean section and offspringʼs risk of inflammatory bowel disease: A national cohort studyInflammatory Bowel Diseases, 2012
- The Impact of the Gut Microbiota on Human Health: An Integrative ViewCell, 2012
- Pregnancy Outcome and Risk of Celiac Disease in Offspring: A Nationwide Case-Control StudyGastroenterology, 2012
- Cesarean Versus Vaginal Delivery: Long-term Infant Outcomes and the Hygiene HypothesisClinics in Perinatology, 2011
- Effect of mother’s weight on infant’s microbiota acquisition, composition, and activity during early infancy: a prospective follow-up study initiated in early pregnancyThe American Journal of Clinical Nutrition, 2010
- Search and clustering orders of magnitude faster than BLASTBioinformatics, 2010
- Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newbornsProceedings of the National Academy of Sciences of the United States of America, 2010
- Caesarean delivery and risk of atopy and allergic disesase: meta‐analysesClinical & Experimental Allergy, 2008
- Administration of Oral Probiotic Bacteria to Pregnant Women Causes Temporary Infantile ColonizationJournal of Pediatric Gastroenterology and Nutrition, 2004